Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Galvamark Met 850mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Galvamark Met 850mg/50mg Tablet

Diabex Duo 850mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and current medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes benefits; discontinuation should only occur under physician guidance. Effective blood sugar control is key to preventing future health issues, so maintaining your prescribed diet and exercise routine is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't suitable for all patients. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Potential drug interactions exist; disclose all medications to your physician to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Galvamark Met 850mg/50mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Galvamark Met 850mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Galvamark Met 850mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Galvamark Met 850mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Galvamark Met 850mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Galvamark Met 850mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Galvamark Met 850mg/50mg Tablet with a meal.

How Galvamark Met 850mg/50mg Tablet works:

Metformin/Glimepiride 850mg/50mg tablets (Galvamark) offer dual antidiabetic action.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Galvamark Met 850mg/50mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Galvamark Met 850mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Galvamark Met 850mg/50mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Galvamark Met 850mg/50mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Galvamark Met 850mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Galvamark Met 850mg/50mg Tablet :

Should you forget a dose of Galvamark Met 850mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Galvamark Met 850mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Galvamark Met 850mg/50mg Tablet

Galvamark Met 850mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Galvamark Met 850mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Galvamark Met 850mg/50mg Tablets are contraindicated in patients allergic to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Galvamark Met 850mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Galvamark Met 850mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is higher in individuals with kidney disease, older adults, and those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Galvamark Met 850mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Galvamark Met 850mg/50mg tablets as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Galvamark Met 850mg/50mg ...
140
MRP 170
17% off